Rose Sharon Shabet, 10% Owner at Urovant Sciences Ltd. (UROV), bought 7,367 shares at $7.95 ($59K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Open-market purchase of $59k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| FIGS | SELL | 2021-09-03 | $18.7M | — | Filing → |
| BBIO | BUY | 2019-06-28 | $80.0M | — | Filing → |
| UROV | BUY | 2019-06-14 | $177K | — | Filing → |